Medicure (MCUJF) Cash from Discontinued Operations (2010 - 2017)

Medicure (MCUJF) recorded quarterly Cash from Discontinued Operations of 23536437.97 in Q4 2017, down 198.78% quarter-over-quarter from 23827261.81 in Q3 2017.

Medicure (MCUJF) Cash from Discontinued Operations (2010 - 2017) Analysis & Trends

Medicure's Cash from Discontinued Operations history runs 3 years deep, the most recent figure standing at 23536437.97 for Q4 2017.

  • In Q4 2017, Cash from Discontinued Operations changed N/A year-over-year to 23536437.97; the TTM figure through Dec 2017 stood at 313038.78 (changed N/A YoY), while the FY2017 annual figure was 16186.84, up 200.11% from the prior year.
  • Cash from Discontinued Operations was 23536437.97 for Q4 2017 at Medicure, down from 23827261.81 in the prior quarter.
  • In the past five years, Cash from Discontinued Operations ranged from a high of 23827261.81 in Q3 2017 to a low of 23536437.97 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Medicure - - 2.57 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2017 -23.54 Mn
Dec 31, 2017 -23.54 Mn
Sep 30, 2017 23.83 Mn
Sep 30, 2017 23.83 Mn
Jun 30, 2017 566,857.03
Jun 30, 2017 566,857.03
Mar 31, 2017 -544,642.09
Mar 31, 2017 -544,642.09
Feb 28, 2011 303,623.90
Feb 28, 2011 303,623.90
Feb 28, 2010 297,270.86
Feb 28, 2010 297,270.86